Clinical Trial Update: Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis

View source ↗

Summary

This clinical trial update reports on a completed study examining stimulatory autoantibodies to the platelet-derived growth factor receptor (PDGFR) in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: University of Michigan | Conditions: Systemic Sclerosis | Status: COMPLETED